Health Condition 1: C22- Malignant neoplasm of liver and intrahepatic bile ducts
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Vedanta Medical Research Foundation
Eligibility
Inclusion criteria
Inclusion criteria: The study will include histopathologically confirmed metastatic Biliary tract cancer patients, who were undergoing treatment or at follow-up visit to the hospital during the study period. All adult patients who are aged 18 and above with biliary tract cancer and are willing to participate in the study.
Exclusion criteria
Exclusion criteria: Patients who are below 18 years and are not willing to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To describe the profile and patterns of Biliary Tract cancer in patients availing of care at the reporting hospital. Timepoint: This is an observational study without any intervention. Data will be assessed for all registered patients during two time periods: 1)Retrospective phase: March 2018 to September 2025 2)Prospective phase: October 2025 to June 2027 | — |
Secondary
| Measure | Time frame |
|---|---|
| Screen eligible patients & abstract medical records to describe the diagnostic, staging, & treatment details of Biliary Tract cancer patients.Timepoint: 24 Weeks | — |
Countries
India
Contacts
Public ContactBhawna Sirohi
Vedanta Medical Research Foundation (BALCO Medical Centre)
Outcome results
None listed